Related references
Note: Only part of the references are listed.The Effect of Renal Replacement Therapy and Antibiotic Dose on Antibiotic Concentrations in Critically Ill Patients: Data From the Multinational Sampling Antibiotics in Renal Replacement Therapy Study
Jason A. Roberts et al.
CLINICAL INFECTIOUS DISEASES (2021)
Clinical Pharmacokinetics of Fosfomycin after Continuous Infusion Compared with Intermittent Infusion: a Randomized Crossover Study in Healthy Volunteers
Valentin al Jalali et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2021)
Ceftolozane/tazobactam exposure in critically ill patients undergoing continuous renal replacement therapy: a PK/PD approach to tailor dosing
Milo Gatti et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2021)
Optimizing ceftaroline dosing in critically ill patients undergoing continuous renal replacement therapy
Shamir Kalaria et al.
PHARMACOTHERAPY (2021)
Population Pharmacokinetics of Dalbavancin and Dosing Consideration for Optimal Treatment of Adult Patients with Staphylococcal Osteoarticular Infections
Pier Giorgio Cojutti et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2021)
Poor Correlation between Meropenem and Piperacillin Plasma Concentrations and Delivered Dose of Continuous Renal Replacement Therapy
J. Petersson et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2021)
Should the Clinical Pharmacologist Play a Role in the Multidisciplinary Team Managing Severe Necrotizing Soft-Tissue Infections?
Milo Gatti et al.
CLINICAL PHARMACOKINETICS (2021)
Fosfomycin in continuous or prolonged infusion for systemic bacterial infections: a systematic review of its dosing regimen proposal from in vitro, in vivo and clinical studies
Roberta Maria Antonello et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2021)
Pharmacokinetic/pharmacodynamic target attainment in critically ill renal patients on antimicrobial usage: focus on novel beta-lactams and beta lactams/beta-lactamase inhibitors
Milo Gatti et al.
EXPERT REVIEW OF CLINICAL PHARMACOLOGY (2021)
Antibiotic Dosing for Critically Ill Adult Patients Receiving Intermittent Hemodialysis, Prolonged Intermittent Renal Replacement Therapy, and Continuous Renal Replacement Therapy: An Update
Brian M. Hoff et al.
ANNALS OF PHARMACOTHERAPY (2020)
A Population Pharmacokinetic Model-Guided Evaluation of Ceftolozane-Tazobactam Dosing in Critically Ill Patients Undergoing Continuous Venovenous Hemodiafiltration
Fekade B. Sime et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2020)
Ceftolozane Pharmacokinetics in a Septic Critically Ill Patient under Different Extracorporeal Replacement Therapies
Nieves Carbonell et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2020)
Emerging Treatment Options for Infections by Multidrug-Resistant Gram-Positive Microorganisms
Despoina Koulenti et al.
MICROORGANISMS (2020)
Pharmacokinetic and pharmacodynamic considerations in antimicrobial therapy for sepsis
Motoki Fujii et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2020)
Meropenem/vaborbactam: a next generation β-lactam β-lactamase inhibitor combination
Andrea Novelli et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2020)
Therapeutic Drug Monitoring of Dalbavancin Treatment in Severe Necrotizing Fasciitis in 3 Critically Ill Patients: A Grand Round
Alberto Corona et al.
THERAPEUTIC DRUG MONITORING (2020)
Recommendation of Antimicrobial Dosing Optimization During Continuous Renal Replacement Therapy
Lu Li et al.
FRONTIERS IN PHARMACOLOGY (2020)
Ceftolozane/Tazobactam for Treatment of Severe ESBL-Producing Enterobacterales Infections: A Multicenter Nationwide Clinical Experience (CEFTABUSE II Study)
Matteo Bassetti et al.
OPEN FORUM INFECTIOUS DISEASES (2020)
Clinical pharmacokinetics of ceftolozane and tazobactam in an obese patient receiving continuous venovenous haemodia filtration: A patient case and literature review
Ahmed Mahmoud et al.
JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE (2020)
Optimizing ceftolozane-tazobactam dosage during continuous renal replacement therapy: some nuances
Gerardo Aguilar et al.
CRITICAL CARE (2020)
New beta-Lactam-beta-Lactamase Inhibitor Combinations
Dafna Yahav et al.
CLINICAL MICROBIOLOGY REVIEWS (2020)
Clinical Pharmacokinetics and Pharmacodynamics of Ceftazidime-Avibactam Combination: A Model-Informed Strategy for its Clinical Development
Sherwin K. B. Sy et al.
CLINICAL PHARMACOKINETICS (2019)
In vivo pharmacokinetic analysis of meropenem/vaborbactam during continuous venovenous haemodialysis
Wesley D. Kufel et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2019)
A Guide to Understanding Antimicrobial Drug Dosing in Critically Ill Patients on Renal Replacement Therapy
Valentina Pistolesi et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)
Evaluation of Proteins and Cells that Adsorb to Dialysis Membranes Used in Continuous Hemodiafiltration: Comparison of AN69ST, Polymethylmethacrylate, and Polysulfone Membranes
Junichi Michikoshi et al.
BLOOD PURIFICATION (2019)
What Antibiotic Exposures Are Required to Suppress the Emergence of Resistance for Gram-Negative Bacteria? A Systematic Review
Chandra Datta Sumi et al.
CLINICAL PHARMACOKINETICS (2019)
Pharmacokinetic and Pharmacodynamic Profiles of Cefiderocol, a Novel Siderophore Cephalosporin
Takayuki Katsube et al.
CLINICAL INFECTIOUS DISEASES (2019)
Steady-State Ceftazidime-Avibactam Serum Concentrations and Dosing Recommendations in a Critically Ill Patient Being Treated for Pseudomonas aeruginosa Pneumonia and Undergoing Continuous Venovenous Hemodiafiltration
Paige Soukup et al.
PHARMACOTHERAPY (2019)
Ceftolozane/tazobactam for the treatment of serious Pseudomonas aeruginosa infections: a multicentre nationwide clinical experience
Matteo Bassetti et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2019)
Population pharmacokinetics and simulations of imipenem in critically ill patients undergoing continuous renal replacement therapy
Sanwang Li et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2019)
Optimizing ceftolozane-tazobactam dosage in critically ill patients during continuous venovenous hemodiafiltration
Gerardo Aguilar et al.
CRITICAL CARE (2019)
Optimizing ceftolozane-tazobactam dosage during continuous renal replacement therapy: additional insights
Patrick M. Honore et al.
CRITICAL CARE (2019)
Optimization of the treatment with beta-lactam antibiotics in critically ill patientsguidelines from the French Society of Pharmacology and Therapeutics (Societe Francaise de Pharmacologie et TherapeutiqueSFPT) and the French Society of Anaesthesia and Intensive Care Medicine (Societe Francaise d'Anesthesie et ReanimationSFAR)
Romain Guilhaumou et al.
CRITICAL CARE (2019)
Physical and chemical stability of ceftaroline in an elastomeric infusion device
Farah Al Madfai et al.
EUROPEAN JOURNAL OF HOSPITAL PHARMACY (2018)
Treatment of Infections Caused by Extended-Spectrum-Beta-Lactamase-, AmpC-, and Carbapenemase-Producing Enterobacteriaceae
Jesus Rodriguez-Bano et al.
CLINICAL MICROBIOLOGY REVIEWS (2018)
Disposition of ceftobiprole during continuous venous-venous hemodiafiltration (CVVHDF) in a single critically ill patient
Pier Giorgio Cojutti et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2018)
Imipenem-Relebactam and Meropenem-Vaborbactam: Two Novel Carbapenem-beta-Lactamase Inhibitor Combinations
George G. Zhanel et al.
DRUGS (2018)
Acute kidney injury in sepsis
Rinaldo Bellomo et al.
INTENSIVE CARE MEDICINE (2017)
Impact of β-lactam antibiotic therapeutic drug monitoring on dose adjustments in critically ill patients undergoing continuous renal replacement therapy
Caleb J. P. Economou et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2017)
Impact of renal replacement modalities on the clearance of piperacillin-tazobactam administered via continuous infusion in critically ill patients
Claire Roger et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2017)
Review of the pharmacokinetics of dalbavancin, a recently approved lipoglycopeptide antibiotic
Ranjeet Prasad Dash et al.
INFECTIOUS DISEASES (2017)
Ex vivo Ceftolozane/Tazobactam Clearance during Continuous Renal Replacement Therapy
Weerachai Chaijamorn et al.
BLOOD PURIFICATION (2017)
Ceftolozane-Tazobactam Pharmacokinetics in a Critically Ill Patient on Continuous Venovenous Hemofiltration
Wesley D. Oliver et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Pharmacokinetics and Dosing of Ceftobiprole Medocaril for the Treatment of Hospital- and Community-Acquired Pneumonia in Different Patient Populations
Antonio Torres et al.
CLINICAL PHARMACOKINETICS (2016)
Treatment of multidrug-resistant Pseudomonas aeruginosa with ceftolozane/tazobactam in a critically ill patient receiving continuous venovenous haemodiafiltration
Joseph L. Kuti et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2016)
Antimicrobial Resistance
Hilary D. Marston et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
Piperacillin population pharmacokinetics in critically ill patients with multiple organ dysfunction syndrome receiving continuous venovenous haemodiafiltration: effect of type of dialysis membrane on dosing requirements
Marta Ulldemolins et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2016)
n Ceftolozane/Tazobactam Pharmacokinetics in a Critically Ill Adult Receiving Continuous Renal Replacement Therapy
Derek N. Bremmer et al.
PHARMACOTHERAPY (2016)
Exploration of the Pharmacokinetic-Pharmacodynamic Relationships for Fosfomycin Efficacy Using an In Vitro Infection Model
Brian D. VanScoy et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Meropenem Population Pharmacokinetics in Critically Ill Patients with Septic Shock and Continuous Renal Replacement Therapy: Influence of Residual Diuresis on Dose Requirements
Marta Ulldemolins et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
To increase or decrease dosage of antimicrobials in septic patients during continuous renal replacement therapy: the eternal doubt
Wai-Tat Wong et al.
CURRENT OPINION IN PHARMACOLOGY (2015)
How can we ensure effective antibiotic dosing in critically ill patients receiving different types of renal replacement therapy?
Janattul-Ain Jamal et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2015)
Ceftolozane/Tazobactam: A Novel Cephalosporin/β-Lactamase Inhibitor Combination
Jonathan C. Cho et al.
PHARMACOTHERAPY (2015)
A multicenter study on the effect of continuous hemodiafiltration intensity on antibiotic pharmacokinetics
Darren M. Roberts et al.
CRITICAL CARE (2015)
Pharmacokinetic and pharmacodynamic evaluation of ceftaroline fosamil
Andrew Merker et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2014)
Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions
Jason A. Roberts et al.
LANCET INFECTIOUS DISEASES (2014)
A comparison of CKD-EPI estimated glomerular filtration rate and measured creatinine clearance in recently admitted critically ill patients with normal plasma creatinine concentrations
Andrew A. Udy et al.
BMC NEPHROLOGY (2013)
Variability of antibiotic concentrations in critically ill patients receiving continuous renal replacement therapy: A multicentre pharmacokinetic study
Darren M. Roberts et al.
CRITICAL CARE MEDICINE (2012)
Recommended beta-lactam regimens are inadequate in septic patients treated with continuous renal replacement therapy
Lucie Seyler et al.
CRITICAL CARE (2011)
Antibiotics in critically ill patients: a systematic review of the pharmacokinetics of beta-lactams
Joao Goncalves-Pereira et al.
CRITICAL CARE (2011)
Modeled Dalbavancin Transmembrane Clearance during Intermittent and Continuous Renal Replacement Therapies
A. Mary Vilay et al.
BLOOD PURIFICATION (2010)
Clinical significance of the pharmacokinetic and pharmacodynamic characteristics of fosfomycin for the treatment of patients with systemic infections
Nikos Roussos et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2009)
Bench-to-bedside review: Appropriate antibiotic therapy in severe sepsis and septic shock - does the dose matter?
Federico Pea et al.
CRITICAL CARE (2009)
Adis drug profile - Dalbavancin
Vanessa R. Anderson et al.
DRUGS (2008)
Pharmacokinetic considerations for antimicrobial therapy in patients receiving renal replacement therapy
Federico Pea et al.
CLINICAL PHARMACOKINETICS (2007)
Single-dose pharmacokinetics of fosfomycin during continuous venovenous haemofiltration
Rainer Gattringer et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2006)
Acute renal failure in critically ill patients - A multinational, multicenter study
S Uchino et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
Share Paper
